文献速递角膜与眼表疾病

基于CRISPR的RID-MyC检测在涂片和培养阴性真菌性角膜炎中的诊断准确性

Diagnostic Accuracy of a CRISPR-Based Assay in Smear- and Culture-Negative Fungal Keratitis.
PubMed 文献 · JAMA Ophthalmol · 2026-01-01

这项前瞻性诊断准确性研究在印度Aravind眼科医院纳入41例临床疑似微生物性角膜炎但涂片和培养阴性的患者,以活体共聚焦显微镜(IVCM)为参考标准评估RID-MyC检测。结果显示RID-MyC灵敏度82.1%、特异度76.9%,与IVCM的一致率为80.5%,提示其可作为常规诊断的实用辅助工具。

要点

  • RID-MyC检测涂片和培养阴性真菌性角膜炎的灵敏度为82.1%,特异度为76.9%。
  • RID-MyC与IVCM的诊断一致率为80.5%(33/41例)。
  • RID-MyC快速且设备需求少,或可在IVCM不可用或禁忌的资源有限地区作为辅助诊断。

核心结论

  • 在涂片和培养阴性的真菌性角膜炎患者中,RID-MyC检测显示出与IVCM相当的较好诊断准确性,且所有病例均可行。

研究设计与样本

  • 最终分析纳入41例患者,平均年龄51.0岁(SD 14.6),女性21例(51.2%)。
  • 所有纳入者均接受角膜刮片行RID-MyC检测和IVCM成像,以IVCM为参考标准。

主要发现

  • RID-MyC灵敏度为82.1%(95% CI,63%-94%),特异度为76.9%(95% CI,46%-95%)。
  • 阳性预测值为88.5%(95% CI,74%-95%),阴性预测值为66.7%(95% CI,46%-82%)。
  • RID-MyC与IVCM的一致率为80.5%(33/41例)。
  • IVCM阳性但RID-MyC阴性的患者中,既往抗真菌治疗最常见(4/5,80%)。
  • IVCM阴性但RID-MyC阳性的患者(3/3,100%)均存在较小、周边或旁中心病灶。

关键数值与推荐

  • 以IVCM为参考标准,RID-MyC灵敏度82.1%(95% CI,63%-94%)、特异度76.9%(95% CI,46%-95%)。
  • 阳性预测值88.5%(95% CI,74%-95%),阴性预测值66.7%(95% CI,46%-82%)。
  • 诊断一致率80.5%(33/41例)。

临床怎么用

  • 对于涂片和培养阴性的疑似真菌性角膜炎患者,RID-MyC可作为IVCM的辅助诊断手段。
  • 在IVCM不可用或禁忌的高负担、资源有限环境中,RID-MyC因快速 turnaround 和 minimal equipment needs 具有实用价值。

局限性

  • 最终分析样本量较小(41例),可能导致置信区间较宽。
  • 以IVCM而非微生物培养或临床结局作为参考标准,可能影响诊断准确性评估。
  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Diagnosing fungal keratitis (FK) in patients with negative smear and culture results remains clinically challenging, highlighting the need for alternative diagnostic approaches. OBJECTIVE: To determine the diagnostic accuracy of the clustered regularly interspaced short palindromic repeats (CRISPR)-based Rapid Identification of Mycoses using CRISPR (RID-MyC) assay for detecting FK in patients with negative smear and culture results using in vivo confocal microscopy (IVCM) as the reference standard. DESIGN, SETTING, AND PARTICIPANTS: This prospective diagnostic accuracy study was conducted from December 2024 to March 2025 at Aravind Eye Hospital, a tertiary ophthalmology referral hospital in Coimbatore, India. Consecutive patients clinically suspected to have microbial keratitis with negative smear and culture results were eligible for inclusion. Data were analyzed from March 2025 to June 2025. INTERVENTIONS: All included participants underwent corneal scraping for RID-MyC assay and imaging by IVCM. MAIN OUTCOMES AND MEASURES: The primary outcomes were sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic concordance of the RID-MyC assay compared with IVCM results. RESULTS: Of 245 consecutive patients clinically suspected to have microbial keratitis, 82 were smear negative. After exclusions due to contraindications or positive subsequent cultures, 41 patients with smear- and culture-negative results were ultimately included in the final analysis. Of these 41 patients (mean [SD] age, 51.0 [14.6] years; 21 [51.2%] women), RID-MyC demonstrated sensitivity of 82.1% (95% CI, 63%-94%) and specificity of 76.9% (95% CI, 46%-95%). Positive predictive value was 88.5% (95% CI, 74%-95%) and negative predictive value was 66.7% (95% CI, 46%-82%). Concordance between RID-MyC and IVCM was observed in 33 cases (80.5%). Notably, prior antifungal treatment was most frequent (4 of 5 [80%]) among patients with positive IVCM but negative RID-MyC results. Conversely, all patients (3 of 3 [100%]) with negative IVCM but positive RID-MyC findings had smaller, peripheral, or paracentral lesions. CONCLUSIONS AND RELEVANCE: In this diagnostic study, in patients with smear- and culture-negative FK, the RID-MyC assay showed good diagnostic accuracy comparable with IVCM and was feasible in all cases, including those in whom imaging was not possible. With its rapid turnaround and minimal equipment needs, RID-MyC may serve as a practical adjunct to conventional diagnostics, particularly in high-burden, resource-limited settings where IVCM is unavailable or contraindicated.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Deivarajan HR, Nachammai D, Nandhakumar D, et al. Diagnostic Accuracy of a CRISPR-Based Assay in Smear- and Culture-Negative Fungal Keratitis. JAMA Ophthalmol. 2026. PMID: 41784973. doi:10.1001/jamaophthalmol.2026.0113

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。